237 related articles for article (PubMed ID: 17560009)
1. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
Kim WI; Wiesner SM; Largaespada DA
Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.
Almarza E; Segovia JC; Guenechea G; Gómez SG; Ramírez A; Bueren JA
Exp Hematol; 2004 Apr; 32(4):360-4. PubMed ID: 15050746
[TBL] [Abstract][Full Text] [Related]
3. Adjusting transgene expression levels in lymphocytes with a set of inducible promoters.
Danke C; Grünz X; Wittmann J; Schmidt A; Agha-Mohammadi S; Kutsch O; Jäck HM; Hillen W; Berens C
J Gene Med; 2010 Jun; 12(6):501-15. PubMed ID: 20527043
[TBL] [Abstract][Full Text] [Related]
4. Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.
Uchida S; Sakai S; Furuichi T; Hosoda H; Toyota K; Ishii T; Kitamoto A; Sekine M; Koike K; Masushige S; Murphy G; Silva AJ; Kida S
Genes Brain Behav; 2006 Feb; 5(1):96-106. PubMed ID: 16436193
[TBL] [Abstract][Full Text] [Related]
5. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
6. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.
Freundlieb S; Schirra-Müller C; Bujard H
J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580
[TBL] [Abstract][Full Text] [Related]
7. A system for inducible gene expression in retinal ganglion cells.
Kerrison JB; Duh EJ; Yu Y; Otteson DC; Zack DJ
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2932-9. PubMed ID: 16043868
[TBL] [Abstract][Full Text] [Related]
8. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
9. Highly suppressible expression of single-chain interleukin-12 by doxycycline following adenoviral infection with a single-vector Tet-regulatory system.
Block A; Puls F; Müller J; Milasinovic D; Igelmann D; Schäfer P; Kupfermann N; Schmoldt A; Ameis D; Greten H
J Gene Med; 2003 Mar; 5(3):190-200. PubMed ID: 12666185
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human CD7 transgenic mice.
Schanberg LE; Lee DM; Fleenor DE; Ware RE; Patel DD; Haynes BF; Kaufman RE
J Immunol; 1995 Sep; 155(5):2407-18. PubMed ID: 7544374
[TBL] [Abstract][Full Text] [Related]
11. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system.
Hennighausen L; Wall RJ; Tillmann U; Li M; Furth PA
J Cell Biochem; 1995 Dec; 59(4):463-72. PubMed ID: 8749716
[TBL] [Abstract][Full Text] [Related]
12. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
[TBL] [Abstract][Full Text] [Related]
13. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
Cory S; Harris AW; Strasser A
Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
[TBL] [Abstract][Full Text] [Related]
14. Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse.
Wiesner SM; Jones JM; Hasz DE; Largaespada DA
Blood; 2005 Aug; 106(3):1054-62. PubMed ID: 15831708
[TBL] [Abstract][Full Text] [Related]
15. Inducible gene expression with the Tet-on system in CD4+ T cells and thymocytes of mice.
Huai J; Firat E; Niedermann G
Genesis; 2007 Jul; 45(7):427-31. PubMed ID: 17603790
[TBL] [Abstract][Full Text] [Related]
16. Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.
Qu Z; Thottassery JV; Van Ginkel S; Manuvakhova M; Westbrook L; Roland-Lazenby C; Hays S; Kern FG
Gene; 2004 Feb; 327(1):61-73. PubMed ID: 14960361
[TBL] [Abstract][Full Text] [Related]
17. Expression of the vav oncogene in somatic cell hybrids.
Denkinger DJ; Kawahara RS
Exp Cell Res; 1997 May; 232(2):388-94. PubMed ID: 9168816
[TBL] [Abstract][Full Text] [Related]
18. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
[TBL] [Abstract][Full Text] [Related]
19. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector.
Adams JM; Harris AW; Strasser A; Ogilvy S; Cory S
Oncogene; 1999 Sep; 18(38):5268-77. PubMed ID: 10498879
[TBL] [Abstract][Full Text] [Related]
20. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
